Literature DB >> 8042815

Rapid 1% increases of end-tidal desflurane concentration to greater than 5% transiently increase heart rate and blood pressure in humans.

M A Moore1, R B Weiskopf, E I Eger, M Noorani, L McKay, M Damask.   

Abstract

BACKGROUND: Large (0.5-1.0 MAC), rapid increases of desflurane to concentrations greater than 5% can transiently increase heart rate, mean arterial blood pressure (MAP), sympathetic nerve activity, and plasma epinephrine concentration. We tested the hypothesis that small (1% = 0.14 MAC), rapid increases of desflurane concentration to greater than 5% do not increase heart rate, blood pressure, and plasma catecholamine concentrations.
METHODS: Anesthesia was induced with intravenous propofol, 2 mg/kg, in 13 healthy male volunteers, 19-33 yr of age, and ventilation was controlled to maintain normocapnia. We gave 4% end-tidal desflurane in oxygen for 32 min and then imposed successive 1% increases in end-tidal desflurane concentration, each new concentration maintained for 4 min, to a final concentration of 12%. We measured heart rate, MAP and plasma catecholamine concentrations in the awake state, after 4 min at each 1% step, and at times of peak increase of MAP (> or = 10% change).
RESULTS: Increases in heart rate and blood pressure of more than 10% occurred with 1% step-increases in only 1 volunteer at 5% desflurane but in 7-10 (MAP) and 8-12 (heart rate) of the 13 volunteers at higher desflurane concentrations. The 1% increases in desflurane concentration to greater than 5% also transiently increased plasma epinephrine concentrations but not vasopressin concentration or plasma renin activity in those volunteers in whom MAP increased.
CONCLUSIONS: Small (1%) increases in desflurane concentration to and greater than 6% can transiently increase heart rate, mean arterial pressure, and plasma epinephrine concentration. These data and those from a previous study indicate that these increases occur with a lesser frequency and magnitude than those associated with a single, rapid step from 4% to 12% end-tidal desflurane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042815     DOI: 10.1097/00000542-199407000-00014

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  The in vitro zebrafish heart as a model to investigate the chronotropic effects of vapor anesthetics.

Authors:  Matthew R Stoyek; Michael K Schmidt; Florentin M Wilfart; Roger P Croll; Frank M Smith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-06       Impact factor: 3.619

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  The Effects of Switching from Sevoflurane to Short-Term Desflurane prior to the End of General Anesthesia on Patient Emergence and Recovery: A Randomized Controlled Trial.

Authors:  Ji Wook Kim; Jeong Yup Lee; Si Won Hwang; Dong-Hee Kang; Sie Jeong Ryu; Doo Sik Kim; Ju Deok Kim
Journal:  Biomed Res Int       Date:  2022-07-06       Impact factor: 3.246

Review 4.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

5.  Effect-site concentration of remifentanil for minimizing cardiovascular changes by inhalation of desflurane.

Authors:  Hee Jin Jeong; Hee Jung Baik; Jong Hak Kim; Youn Jin Kim; Jae Hyon Bahk
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

6.  Desflurane - revisited.

Authors:  Mukul Chandra Kapoor; Mahesh Vakamudi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.